Research and Markets (http://www.researchandmarkets.com/research/tpcp38/cancer) has announced the addition of the "Cancer Immunotherapy Market & Clinical Pipeline Insight" report to their offering.
Cancer immunotherapy will continue to be overflowing with huge potential as a result of an increasing number of new discoveries and techniques. Inspite of advances being made in terms of understanding of the complexities of the human immune system, as compared to the state of immunology during Dr. Coley, there is still significant work which needs to be done. The complete detailed understanding is yet to be deciphered, which is one of the major reasons for cancer immunotherapy not being in widespread use.
Report Highlights:
- Cancer Immunotherapy Market & Clinical Pipeline Insight
- Cancer Immunotherapy Market Overview
- Cancer Immunotherapy Market Dynamics
- Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline
- Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country
- Cancer Vaccine Clinical Pipeline by Phase & Country
- Oncolytic Viruses Clinical Pipeline by Phase & Country
- Cancer Cytokine Therapy Clinical Trial Insight by Phase & Country
- Cancer Cell Therapy Clinical Trial Insight by Phase & Country
- Currently there are 605 Cancer Monoclonal Antibodies, 289 Cancer Vaccines, 40 Oncolytic Viruses Drugs, 64 Cytokines Therapies & 82 Cell Therapies are in Clinical Pipeline
Key Topics Covered:
1. Introduction to Cancer Immunotherapy
2. Mechanism of Cancer Immunotherapy
3. Types of Cancer Immunotherapy
4. Why Need for Cancer Immunotherapy
5. Global Cancer Immunotherapy Market Overview
6. Cancer Immunotherapy Market Dynamics
7. Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country
8. Cancer Vaccine Clinical Pipeline by Phase & Country
9. Oncolytic Viruses Clinical Pipeline by Phase & Country
10. Cancer Cytokine Therapy Clinical Trial Insight by Phase & Country
11. Cancer Cell Therapy Clinical Trial Insight by Phase & Country
12. Competitive Landscape: Business Overview & Product Pipeline
- Advaxis
- CelldexTherapeutics
- DendreonCorporation
- GalenaBiopharma
- ImmunoCellularTherapeutics
- ImmunoGen
- InovioPharmaceuticals
- Merck
- NeoStemOncology
- NewLinkGenetics
- NorthwestBiotherapeutics
- Novartis
- PeregrinePharmaceuticals
- Roche
- SeattleGenetics
For more information visit http://www.researchandmarkets.com/research/tpcp38/cancer
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals